纽约州总检察长莉蒂夏·詹姆斯7月15日宣布，其办公室联合全美48州总检察长与生物制药巨头吉利德科学公司（GILD.O）达成和解协议，该公司将支付2.02亿美元以了结关于其艾滋病治疗药物定价过高的指控。
该和解源于对吉利德涉嫌操纵药品定价行为的联合调查。詹姆斯在社交媒体声明中指出，此次多州协作成功促使制药企业承担相应责任。调查发现，吉利德被控通过不当手段维持包括艾滋病治疗药物在内的药品垄断定价，最终损害了医疗体系与患者的利益。
根据协议条款，和解金将分配至参与诉讼的各州，用于补偿因药品高价导致的医疗系统损失。这项创纪录的和解彰显了州级司法部门对制药行业定价行为的监管力度正在持续加强。截至发稿，吉利德科学尚未就具体和解细节发表进一步评论。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.